Pierre Guermonprez1,2, Julie Helft3. 1. Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immmunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. pierre.guermonprez@kcl.ac.uk. 2. Centre for Inflammation Research, CNRS ERL8252, INSERM1149, Paris Diderot, Sorbonne Paris Cité University, Paris, France. pierre.guermonprez@kcl.ac.uk. 3. Institut Curie, PSL Research University, Immunity and Cancer Department, INSERM U932, Paris, France. julie.helft@curie.fr.
Authors: Antoni Olona; Subhankar Mukhopadhyay; Charlotte Hateley; Fernando O Martinez; Siamon Gordon; Jacques Behmoaras Journal: BMC Biol Date: 2021-11-19 Impact factor: 7.431